Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 75

1.

Longitudinal pattern of pain medication utilization in peripheral neuropathy patients.

Callaghan BC, Reynolds E, Banerjee M, Kerber KA, Skolarus LE, Burke JF.

Pain. 2018 Nov 5. doi: 10.1097/j.pain.0000000000001439. [Epub ahead of print]

PMID:
30418352
2.

Assessment of Proposed Changes to Evaluation and Management Billing Levels by Physician Specialty.

Callaghan BC, Burke JF, Skolarus LE, Kerber KA.

JAMA Neurol. 2018 Oct 31. doi: 10.1001/jamaneurol.2018.3794. [Epub ahead of print] No abstract available.

PMID:
30383157
3.

Unintended consequences of Mayo paraneoplastic evaluations.

Ebright MJ, Li SH, Reynolds E, Burke JF, Claytor BR, Grisold A, Banerjee M, Callaghan BC.

Neurology. 2018 Nov 27;91(22):e2057-e2066. doi: 10.1212/WNL.0000000000006577. Epub 2018 Oct 26.

PMID:
30366974
4.

Reply to "Diagnosing Neuropathy in an Obese Patient": Measuring neuropathy in obese populations: Nerve conduction studies.

Callaghan BC, Feldman EL.

Clin Neurophysiol. 2018 Sep;129(9):2050. doi: 10.1016/j.clinph.2018.06.004. Epub 2018 Jun 14. No abstract available.

PMID:
29921550
5.

Measuring neuropathy in obese populations: Challenge accepted. Reply to "Diagnostic accuracy of neuropathy tests in obese population remains elusive".

Callaghan BC, Feldman EL.

Clin Neurophysiol. 2018 Jul;129(7):1504-1505. doi: 10.1016/j.clinph.2018.03.040. Epub 2018 Apr 16. No abstract available.

PMID:
29729887
6.

What's happening in Innovations in Care Delivery.

Callaghan BC, Kerber KA.

Neurology. 2018 May 1;90(18):841. doi: 10.1212/WNL.0000000000005433. No abstract available.

PMID:
29712805
7.

Diabetes and obesity are the main metabolic drivers of peripheral neuropathy.

Callaghan BC, Gao L, Li Y, Zhou X, Reynolds E, Banerjee M, Pop-Busui R, Feldman EL, Ji L.

Ann Clin Transl Neurol. 2018 Feb 14;5(4):397-405. doi: 10.1002/acn3.531. eCollection 2018 Apr.

8.

What's happening in Innovations in Care Delivery.

Callaghan BC, Kerber KA.

Neurology. 2018 Apr 3;90(14):651. doi: 10.1212/WNL.0000000000005273. No abstract available.

PMID:
29610227
9.

What's Happening In Innovations in Care Delivery.

Callaghan BC, Kerber KA.

Neurology. 2018 Mar 6;90(10):463. doi: 10.1212/WNL.0000000000005136. No abstract available.

PMID:
29507132
10.

Association of neurologist care with headache expenditures: A population-based, longitudinal analysis.

Ney JP, Sico JJ, Klein BC, Magliocco B, Callaghan BC, Esper GJ.

Cephalalgia. 2018 Oct;38(12):1876-1884. doi: 10.1177/0333102418762572. Epub 2018 Mar 4.

PMID:
29504480
11.

Risk Factors for Incident Diabetic Polyneuropathy in a Cohort With Screen-Detected Type 2 Diabetes Followed for 13 Years: ADDITION-Denmark.

Andersen ST, Witte DR, Dalsgaard EM, Andersen H, Nawroth P, Fleming T, Jensen TM, Finnerup NB, Jensen TS, Lauritzen T, Feldman EL, Callaghan BC, Charles M.

Diabetes Care. 2018 May;41(5):1068-1075. doi: 10.2337/dc17-2062. Epub 2018 Feb 27.

PMID:
29487078
12.

What's happening in Innovations in Care Delivery.

Callaghan BC, Kerber KA.

Neurology. 2018 Feb 6;90(6):274. doi: 10.1212/WNL.0000000000004941. No abstract available.

PMID:
29438020
13.

Better diagnostic accuracy of neuropathy in obesity: A new challenge for neurologists.

Callaghan BC, Xia R, Reynolds E, Banerjee M, Burant C, Rothberg A, Pop-Busui R, Villegas-Umana E, Feldman EL.

Clin Neurophysiol. 2018 Mar;129(3):654-662. doi: 10.1016/j.clinph.2018.01.003. Epub 2018 Jan 16.

PMID:
29414409
14.

The association of neurologists with headache health care utilization and costs.

Callaghan BC, Burke JF, Kerber KA, Skolarus LE, Ney JP, Magliocco B, Esper GJ.

Neurology. 2018 Feb 6;90(6):e525-e533. doi: 10.1212/WNL.0000000000004925. Epub 2018 Jan 10.

PMID:
29321226
15.

Obesity and the nervous system: more questions - Authors' reply.

Callaghan BC, O'Brien PD, Hinder LM, Feldman EL.

Lancet Neurol. 2017 Oct;16(10):774. doi: 10.1016/S1474-4422(17)30293-4. Epub 2017 Sep 12. No abstract available.

PMID:
28920882
16.

Dizziness Symptom Type Prevalence and Overlap: A US Nationally Representative Survey.

Kerber KA, Callaghan BC, Telian SA, Meurer WJ, Skolarus LE, Carender W, Burke JF.

Am J Med. 2017 Dec;130(12):1465.e1-1465.e9. doi: 10.1016/j.amjmed.2017.05.048. Epub 2017 Jul 21.

PMID:
28739195
17.

Electrodiagnostic tests are unlikely to change management in those with a known cause of typical distal symmetric polyneuropathy.

Callaghan BC, Burke JF, Kerber KA, Albers JW, Feldman EL.

Muscle Nerve. 2017 Sep;56(3):E25. doi: 10.1002/mus.25713. Epub 2017 Jun 22. No abstract available.

18.

Neurological consequences of obesity.

O'Brien PD, Hinder LM, Callaghan BC, Feldman EL.

Lancet Neurol. 2017 Jun;16(6):465-477. doi: 10.1016/S1474-4422(17)30084-4. Review.

19.

Author response: Neuroimaging overuse is more common in Medicare compared with the VA.

Burke JF, Callaghan BC.

Neurology. 2017 Feb 7;88(6):608. doi: 10.1212/WNL.0000000000003594. No abstract available.

PMID:
28167625
20.

Author response: Neuroimaging overuse is more common in Medicare compared with the VA.

Burke JF, Callaghan BC.

Neurology. 2017 Feb 7;88(6):607-608. doi: 10.1212/WNL.0000000000003581. No abstract available.

PMID:
28167623

Supplemental Content

Loading ...
Support Center